Geriatric Medicine

Top Story

Transition to denosumab monotherapy after combination results in favorable BMD changes

June 22, 2017

Postmenopausal women with osteoporosis who switched from combination denosumab therapy to denosumab monotherapy experienced the most favorable total and cortical volumetric bone mineral density changes compared with switching from denosumab to teriparatide or from teriparatide to denosumab.

Joy N. Tsai, MD, of the endocrine unit at Massachusetts General Hospital, and colleagues evaluated data from 679 postmenopausal women with osteoporosis to determine the effect on BMD of switching from teriparatide (Forteo, Eli Lilly) to denosumab as part of the DATA-Switch HR-pQCT study.

Senate health care bill takes slower approach to House bill, expert concerns persist

June 22, 2017
The Senate health care bill, released to the public today, maintains much from the version the House passed May 4, 2017, but presents some key changes such as a slower…
In the Journals Plus

Cost of hospital-based end-of-life care high for elderly with brain tumors

June 22, 2017
Hospital-based end-of-life care for elderly patients with malignant brain tumors is associated with up to $16,000 in expenses, according to a research letter published…
In the Journals

Microvascular dysfunction may increase risk for late-life depression

June 22, 2017
Peripheral and cerebral forms of microvascular dysfunction were associated with increased risk for depression, according to recent findings. “Evidence suggests a…

AMA supports efforts to improve substance abuse disorder coverage

June 21, 2017
Experts from four leading nonprofits in the addiction field have determined that existing legislation does not adequately protect insurance coverage of substance abuse…
More News Headlines »
Instrument Development

Developing the Supporting Choice Observational Tool (SCOT): A Formative Assessment Tool to Assist Nursing Home Staff in Realizing Resident Choice

Research in Gerontological Nursing, May/June 2017, Volume 10 Issue 3
Quality of care in nursing homes has begun to address the importance of resident choice in daily life, yet there are no…
More »

Redefining the Management of Parkinson's Disease Psychosis: A Meeting of the Minds

This activity is supported by an educational grant from Acadia Pharmaceuticals, Inc.

The motor symptoms associated with Parkinson's disease (PD) are well recognized, but the non-motor symptoms are…
More »
Meeting News Coverage

VIDEO: Psychological benefits of neuromodulator injections

September 26, 2016
More »